TrialPath
← All studies
Obesity / overweight

A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

Recruiting · Cypress, California

Study treatment at no costPHASE1, PHASE2

Always free

Study care at no cost to you

For your time and travel

Many studies pay you back

Most need no insurance or papers

Legal status usually isn't required; we'll tell you each study's requirements

Interpreters available

Ask for your language

Your choice

Voluntary — you can stop anytime

What is this study?

This study is designed to test how well the combination of MET233 with MET097 works to treat individuals with obesity or overweight with or without diabetes.

It is , overseen by an independent and licensed medical staff.

Read the full clinical description

This study is designed to test how well the combination of MET233 with MET097 works to treat individuals with obesity or overweight with or without diabetes.

Who this study is looking for

In plain language, from the study's own rules. The study team confirms the full details with you — this isn't a final yes or no.

✅ You may be able to join if…

  • Adults of any sex, age 18 to 75 (inclusive) at screening.
  • BMI in the obesity/overweight range: some parts require BMI 27.0 to 38.0, and other parts require higher BMI ranges (see study rules).
  • Generally stable health based on medical history, physical exam (including vital signs), labs, and ECG.
  • Women who could become pregnant must agree to use birth control as required and must not plan pregnancy during the study.
  • People who can follow all study visits, procedures, and required assessments.

🚫 You may not be able to join if…

  • Anyone pregnant or breastfeeding, or who cannot/will not follow the study’s birth control rules.
  • People with Type 1 diabetes.
  • People whose blood pressure is too high (seated blood pressure higher than 160/100 mmHg at screening or before the first study drug).
  • People with an unusually high resting heart rate (greater than 100 beats per minute at screening or before the first study drug).
  • People with kidney filtering rate too low (eGFR <80 mL/min at screening).

Are you a good fit?

Simplified highlights. The study team always confirms the full details with you.

  • Adults roughly 18–75
  • A BMI around 27 or higher
  • Have Obesity / overweight or Type 2 diabetes or High blood pressure or High cholesterol
  • !Some conditions may not be a fit: Heart / cardiovascular disease, Kidney disease
  • !Not for people who are pregnant or breastfeeding

What to expect, step by step

  1. 1

    Usually a few weeks

    The study team checks whether the study is a good fit for you, with a visit and sometimes lab tests. You can ask any questions before deciding.

  2. 2

    Treatment

    If you join and choose to continue, you receive the study treatment and are watched closely by medical staff.

  3. 3

    Follow-up

    After treatment, the team checks on your health and confirms the visit schedule with you. You can leave the study at any point.

Has this treatment been tested before?

Yes. This treatment has already been through earlier human studies for safety before reaching this stage.

What you need to know before you apply

What is this study testing?+

This study is designed to test how well the combination of MET233 with MET097 works to treat individuals with obesity or overweight with or without diabetes.

Is it safe? Who makes sure of that?+

This is a mid-stage study (Phase 2), looking at safety and whether the treatment works. Every study is reviewed and monitored by an independent ethics board (called an IRB) whose job is to protect participants, and care is overseen by licensed medical staff. You'll be told the known risks before you agree to anything, and you can stop at any time.

Will I get a placebo instead of the real treatment?+

Some studies compare a treatment against a placebo (an inactive version), and some don't. If this one does, the study team will explain your chances of receiving the active treatment before you decide. Nothing is hidden from you.

Do I have to stop taking my current medications?+

It depends on the study. Some let you stay on your current medications and some ask you to adjust them. Never stop a medication on your own — the study team will review everything with you first.

Does it cost anything? Will I be paid?+

The study treatment and study-related visits are provided at no cost to you. Some studies also pay for your time; the coordinator can tell you if this one does. You should never be asked to pay to take part.

Do I need insurance? Will anyone ask about my immigration status?+

No. You do not need health insurance to take part in a research study, and you will not be asked about your immigration status to join. Taking part is about whether you're a medical fit for the study.

What if English isn't my first language?+

You have the right to understand everything before you agree. Study sites can often provide materials or an interpreter in your language — you can ask the coordinator for one.

Is my information private?+

Yes. Your health information is only shared with the study sites you choose to be contacted by, and only to help match and enroll you. It is never sold, and you can ask us to delete it at any time.

Some requirements (like specific lab values or timing) are confirmed directly by the study team, not by us.

Source: ClinicalTrials.gov · NCT06924320 · Locations: California